Literature DB >> 22935516

Ogino et Al. Respond to "the 21st century epidemiologist".

Shuji Ogino1, Andrew H Beck, Emily E King, Mark E Sherman, Danny A Milner, Edward Giovannucci.   

Abstract

Mesh：

Year:  2012        PMID： 22935516      PMCID： PMC3571249          DOI： 10.1093/aje/kws229

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  29 in total

Review 1.  The CpG island methylator phenotype in colorectal cancer: progress and problems.

Authors:  Laura A E Hughes; Carolina A J Khalid-de Bakker; Kim M Smits; Piet A van den Brandt; Daisy Jonkers; Nita Ahuja; James G Herman; Matty P Weijenberg; Manon van Engeland
Journal:  Biochim Biophys Acta       Date:  2011-10-28

Review 2.  Epigenetics and colorectal cancer.

Authors:  Victoria Valinluck Lao; William M Grady
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-18       Impact factor: 46.802

Review 3.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

4.  Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.

Authors:  Laura A E Hughes; Elizabeth J Williamson; Manon van Engeland; Mark A Jenkins; Graham G Giles; John L Hopper; Melissa C Southey; Joanne P Young; Daniel D Buchanan; Michael D Walsh; Piet A van den Brandt; R Alexandra Goldbohm; Matty P Weijenberg; Dallas R English
Journal:  Int J Epidemiol       Date:  2012-04-24       Impact factor: 7.196

Review 5.  Biomarker use in colorectal cancer therapy.

Authors:  Robin K Kelley; Grace Wang; Alan P Venook
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

6.  Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.

Authors:  Shiro Iwagami; Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Keisuke Miyake; Satoshi Ida; Yohei Nagai; Takatsugu Ishimoto; Masaaki Iwatsuki; Yasuo Sakamoto; Yuji Miyamoto; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2011-12-21       Impact factor: 5.344

7.  Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity.

Authors:  Dianke Chen; Shunxin Song; Jiachun Lu; Yanxin Luo; Zuli Yang; Qinghua Huang; Xinhui Fu; Xinjuan Fan; Yisheng Wei; Jianping Wang; Lei Wang
Journal:  Carcinogenesis       Date:  2011-03-10       Impact factor: 4.944

8.  Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

Authors:  Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Jeffrey A Meyerhardt; Kaori Shima; Katsuhiko Nosho; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

9.  Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer.

Authors:  Eva S Schernhammer; Edward Giovannucci; Takako Kawasaki; Bernard Rosner; Charles S Fuchs; Shuji Ogino
Journal:  Gut       Date:  2009-10-14       Impact factor: 23.059

10.  Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women.

Authors:  Paul J Limburg; David Limsui; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-15       Impact factor: 4.254
View more
  7 in total

Review 1.  Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.

Authors:  Tsuyoshi Hamada; NaNa Keum; Reiko Nishihara; Shuji Ogino
Journal:  J Gastroenterol       Date:  2016-10-13       Impact factor: 7.527

Review 2.  Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.

Authors:  Paul Lochhead; Andrew T Chan; Reiko Nishihara; Charles S Fuchs; Andrew H Beck; Edward Giovannucci; Shuji Ogino
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

Review 3.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

Review 4.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Authors:  Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

5.  Molecular pathological epidemiology gives clues to paradoxical findings.

Authors:  Reiko Nishihara; Tyler J VanderWeele; Kenji Shibuya; Murray A Mittleman; Molin Wang; Alison E Field; Edward Giovannucci; Paul Lochhead; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2015-10-07       Impact factor: 8.082

Review 6.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Authors:  Shuji Ogino; Paul Lochhead; Andrew T Chan; Reiko Nishihara; Eunyoung Cho; Brian M Wolpin; Jeffrey A Meyerhardt; Alexander Meissner; Eva S Schernhammer; Charles S Fuchs; Edward Giovannucci
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

7.  A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.

Authors:  Reiko Nishihara; Teppei Morikawa; Aya Kuchiba; Paul Lochhead; Mai Yamauchi; Xiaoyun Liao; Yu Imamura; Katsuhiko Nosho; Kaori Shima; Ichiro Kawachi; Zhi Rong Qian; Charles S Fuchs; Andrew T Chan; Edward Giovannucci; Shuji Ogino
Journal:  Am J Epidemiol       Date:  2013-06-20       Impact factor: 4.897
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.